NICE APPROVES NEW RARE LUNG CANCER TREATMENT FROM ROCHE

15.06.2020 By Emma Morriss, Pharmafield The National Institute for Health and Care Excellence (NICE) has approved a new rare lung cancer treatment. NICE has published its decision to grant a positive final appraisal document (FAD) for the use of Roche’s Rozlytrek®▼...

 

Welcome and Check out our new motion picture!

WATCH OUR VIDEO